Trial · NCT07076706
Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
NCT07076706, Phase 2, Completed, Beijing Dayspring Pharmaceutical Technology Co., Ltd
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia. Trials, record NCT07076706. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07076706
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
- NCT number
- NCT07076706
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 110 participants, actual
- Lead sponsor
- Beijing Dayspring Pharmaceutical Technology Co., Ltd
- Conditions
- Male Pattern of Hair Loss, Androgenic Alopecia, Androgenetic Alopecia (AGA)
- Interventions
- minoxidil + finasteride, minoxidil + finasteride, Placebo foam
- First posted
- 2025-07-22
- Last updated
- 2026-03-03
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in the non-vellus target area hair count(TAHC) at 24 weeks | 24 weeks | |
| Secondary | Hair Growth Questionnaire | 6, 12, 18, 24 weeks | Questionnaire assessing hair condition by participant. The score ranges from 7 to 38, higher scores mean a worse outcome. |
| Secondary | Participant self assessment of treatment satisfaction | 6, ,12, 18, 24 weeks | Treatment satisfaction will be measured with the "Patient Treatment-Effect Satisfaction Evaluation Form", a single-item, self-administered questionnaire with the score ranges from -3 to +3, where a higher score mean a highr satisfaction. |
| Secondary | Investigator Global Assessment(IGA) | 6, 12, 18, 24 weeks | Assessment made by investigator about the global condition of participant's hair. The value ranges from 0 to 4, higher score means a worse outcome. |
| Secondary | Change from baseline in non-vellus target area hair count(TAHC) | 6, 12, 18 weeks | |
| Secondary | Change from baseline in Target Area Hair Width(TAHW) | 6, 12, 18, 24 weeks | Target Area Hair Width (TAHW) is the cumulative hair diameter per unit area in the target area |
| Secondary | Change from baseline in terminal-vellus ratio | 6, 12, 18, 24 weeks | |
| Secondary | Adverse events | up to 28 weeks |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07076706
GET https://conductscience.org/api/trials/v1/NCT07076706/registered